/ Published in 2010, Publication

No selection of nucleoside reverse transcriptase inhibitor resistance associated mutations by acyclovir suppressive therapy in herpes simplex virus-2/HIV-1 dually infected persons.

No selection of nucleoside reverse transcriptase inhibitor resistance associated mutations by acyclovir suppressive therapy in herpes simplex virus-2/HIV-1 dually infected persons.

LeGoff J, Tanton C, Delaugerre C, Weiss HA, Changalucha J, Ross DA, Mugeye K, Belec L, Hayes RJ, Watson-Jones D.
AIDS. 2010 Oct 23;24(16):2595-6. No abstract available.
PMID: 20940537
Related citation

What you can read next

Brief Report: Changes in Nocturnal Heart Rate Variability in People Living With HIV During the First Year of Antiretroviral Therapy Compared With HIV-Uninfected Community Controls.
Hospitalization outcomes in people living with HIV on Dolutegravir-based regimen in Mwanza, Tanzania: a comparative cohort.
Measurement and predictors of adherence in a trial of HSV suppressive therapy in Tanzania

You must be logged in to post a comment.